September 21, 2017 M&A, Partnerships Microscopy

Oxford Instruments collaborates with CASmF Science and Technology Limited in China for developing high performance SPM products

21 September 2017 Oxford Instruments NanoScience announces the long-term collaboration agreement signed with CASmF Science and Technology Limited (CASmF) in China, to jointly develop high precision Scanning Probe Microscope (SPM) products using TeslatronPT, the Cryofree® superconducting magnet system from Oxford Instruments. SPM products form images of surfaces using a physical probe that scans the specimen. The SPM probe when used... Read more

September 21, 2017 Microscopy Product Launch

Product Launch AFM

2017-09-21 | Corporate The atomic force microscope ToscaTM 400 by Anton Paar is available for sale now. This high-end product measures nano-surface properties and was specially designed for industrial users. Thanks to the automation on every level of operation, ToscaTM 400 is easy to handle. Until now atomic force microscopes were complex and rather complicate to operate thus they were... Read more

September 15, 2017 Clinical Research/Diagn. Microscopy

TECENTRIQ GO29695 (NCT02431208) and BO29562 (NCT02631577) partial clinical hold reactive statement

Basel, 15 September 2017 TECENTRIQ GO29695 (NCT02431208) and BO29562 (NCT02631577) partial clinical hold reactive statement Roche (SIX: RO, ROG; OTCQX: RHHBY): Based on emerging safety data from clinical trials evaluating pembrolizumab in combination with either lenalidomide or pomalidomide in multiple myeloma, the FDA has requested that a Phase Ib and a Phase Ib/II TECENTRIQ study... Read more

September 13, 2017 Microscopy

Leica Microsystems is advancing surgical microscopy by integrating enhanced digital technologies directly into the operating microscope

  Four prominent surgeons and Leica Microsystems President Markus Lusser discussed the many ways Leica Microsystems is pushing the boundaries of visualization in the operating environment by integrating digital technologies directly into the surgical microscope.       Seenu M. Hariprasad, MDShui-Chin Lee Professor of Ophthalmology and Visual ScienceChief, Vitreoretinal ServiceThe University of Chicago Medicine,... Read more

September 6, 2017 Microscopy Product Launch

GE Healthcare Launches First-Ever Mammography System that Allows Patients to Control their Compression by Remote Control

WAUKESHA, WI – September 5, 2017 – GE Healthcare announced today FDA 510(k) clearance of an industry-first, patient-assisted mammography device that literally puts women in control of their mammograms. Senographe Pristina Dueta is an innovative remote control that allows women to manage their own compression during the exam performed on the company’s new mammography system,... Read more

September 5, 2017 Microscopy PR/Corporate

Thermo Fisher Scientific to Present at the Morgan Stanley Global Healthcare Conference on September 11, 2017

Thermo Fisher Scientific to Present at the Morgan Stanley Global Healthcare Conference on September 11, 2017 WALTHAM, Mass., Sept. 5, 2017 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, president and chief executive officer, will present at the Morgan Stanley Global Healthcare Conference on Monday,... Read more

August 30, 2017 Acad, Gov/Utilities Microscopy

FDA approves Roche’s Actemra/RoActemra (tocilizumab) for the treatment of CAR T cell-induced cytokine release syndrome

Basel, 30 August 2017 FDA approves Roche’s Actemra/RoActemra (tocilizumab) for the treatment of CAR T cell-induced cytokine release syndrome Actemra/RoActemra is the first FDA-approved treatment for severe or life-threatening cytokine release syndrome induced by CAR T cell therapy CAR T cell therapy is an immunotherapy designed for the treatment of certain cancers This is the... Read more

August 30, 2017 Acad, Gov/Utilities Microscopy

FDA approves Roche’s Actemra/RoActemra (tocilizumab) for the treatment of CAR T cell-induced cytokine release syndrome

Basel, 30 August 2017 FDA approves Roche’s Actemra/RoActemra (tocilizumab) for the treatment of CAR T cell-induced cytokine release syndrome Actemra/RoActemra is the first FDA-approved treatment for severe or life-threatening cytokine release syndrome induced by CAR T cell therapy CAR T cell therapy is an immunotherapy designed for the treatment of certain cancers This is the... Read more